ReviewPlants (Basel, Switzerland)2025
CRISPR-Mediated Genome Editing in Peanuts: Unlocking Trait Improvement for a Sustainable Future.
Review in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genome-wide identification and gene expression analysis of Formin homology 2 (FH2) genes in peanut.BMC plant biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advancements in genome editing have transformed agricultural biotechnology by allowing for precise modifications of DNA. This technology has sparked increasing interest in enhancing important traits of major crops, including peanuts. As a nutritionally rich legume prized for its high oil content, peanut production still faces significant challenges, including disease outbreaks, nutrient deficiencies, and pest infestations. Addressing these challenges is essential for achieving high yields and sustainable cultivation. CRISPR technology, a cutting-edge genome editing tool, has emerged as a powerful platform for improving peanut traits. Its ability to facilitate gene knockouts, regulate gene expression, and introduce targeted genetic changes has accelerated research efforts in this field. The successful applications of CRISPR in peanut improvement, such as increasing oleic acid content and reducing allergenicity, reassure us about the effectiveness and potential of this technology. Despite the complexity of the peanut genome as a polyploid crop, these successes demonstrate the power of genome editing. This review emphasizes the crucial role of genome editing in enhancing peanut traits and outlines the promising future of CRISPR-based approaches in advancing peanut breeding and agricultural productivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.